Neutrophil-to-Lymphocyte Ratio Is a Major Prognostic Factor in Non-small Cell Lung Carcinoma Patients Undergoing First Line Immunotherapy With Pembrolizumab
2022 · Cancer Diagnosis & Prognosis · 26 citations
https://doi.org/10.21873/cdp.10178
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
410
Citations
8
h-index
8
i10-index
Francesca Ambrosio is an academic researcher from Ospedale Antonio Cardarelli. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 8, co-authored 24 publications.
https://doi.org/10.21873/cdp.10178
https://doi.org/10.1016/j.jtho.2025.09.1034
Click to start Chat